Holen Sie sich die Stockscreener-App
2.78
3.35%
0.09
Vorhandelsmarkt:
2.78
Schlusskurs vom Vortag:
$2.69
Offen:
$2.68
24-Stunden-Volumen:
21,612
Relative Volume:
0.67
Marktkapitalisierung:
$11.46M
Einnahmen:
$1.02M
Nettoeinkommen (Verlust:
$-10.36M
KGV:
-0.4465
EPS:
-6.2265
Netto-Cashflow:
$-8.76M
1W Leistung:
-3.14%
1M Leistung:
+11.65%
6M Leistung:
-17.01%
1J Leistung:
+58.86%
1-Tages-Spanne:
$2.68
$2.85
1-Wochen-Bereich:
$2.60
$2.99
52-Wochen-Spanne:
$1.715
$6.78
Sintx Technologies Inc Stock (SINT) Company Profile
Firmenname
Sintx Technologies Inc
Sektor
Branche
Telefon
801-839-3516
Adresse
1885 WEST 2100 STREET, SALT LAKE CITY, UT
Compare SINT vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SINT
Sintx Technologies Inc
|
2.78 | 11.09M | 1.02M | -10.36M | -8.76M | -6.2265 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Sintx Technologies Inc Stock (SINT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-09-12 | Eingeleitet | Ascendiant Capital Markets | Buy |
Sintx Technologies Inc Aktie (SINT) Neueste Nachrichten
Robert Ryan Elmore Net Worth (2026) - GuruFocus
H.C. Wainwright Initiates Sintx Technologies(SINT.US) With Buy Rating, Announces Target Price $10 - 富途牛牛
Sintx Technologies (SINT) president granted 4,910 common shares as equity award - Stock Titan
SINT Initiates Coverage On SINTX Technologies -- Price Target An - GuruFocus
Published on: 2026-04-14 02:01:43 - baoquankhu1.vn
SINT Forecast, Price Target & Analyst Ratings | SINTX TECHNOLOGIES INC (NASDAQ:SINT) - ChartMill
Trend Report: Can Sintx Technologies Inc disrupt its industryBond Market & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Sintx Technologies (NASDAQ:SINT) Given New $12.00 Price Target at Ascendiant Capital Markets - Defense World
SINT Maintains 'Buy' Rating; Target Price Adjusted to $12 by Asc - GuruFocus
Setup Watch: Can Sintx Technologies Inc stock double in the next yearMarket Trend Summary & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Total debt per share of SINTX Technologies, Inc. – LSE:0A8S - TradingView — Track All Markets
EBITDA per share of SINTX Technologies, Inc. – LSE:0A8S - TradingView
Insider Sell: Can Sintx Technologies Inc disrupt its industryDip Buying & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Earnings Update: What is the PEG ratio of Sintx Technologies IncMarket Risk Report & Technical Confirmation Alerts - baoquankhu1.vn
SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution - Orthopedics This Week
SINTX completes first human implant, names new president By Investing.com - Investing.com Australia
Sintx Technologies 2025 10‑K: Revenue $1.018M, Net Loss $10.364M - TradingView
SINTX completes first human implant, names new president - Investing.com
After its first human foot implant, SINTX shifts to 2026 rollout - Stock Titan
Sintx Technologies (SINT) to Release Quarterly Earnings on Monday - Defense World
SINTX Technologies: Advanced Silicon Nitride Ceramics for Biomedical, Technical, and Antipathogenic Applications 72 - Minichart
SINTX Technologies Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Sintx Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
SINTX Technologies (NASDAQ: SINT) outlines 2025 losses, cash and silicon nitride strategy - Stock Titan
SINTX completes first surgery with foot and ankle implant system By Investing.com - Investing.com India
SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant - Orthopedics This Week
SINTX Technologies (SINT) Achieves Milestone with First Surgical Use of New System - GuruFocus
SINTX completes first surgery with foot and ankle implant system - Investing.com
Sintx Technologies announces first-in-human surgery using FDA-cleared Sinaptic® Foot & Ankle Implant - marketscreener.com
A new foot implant reaches its first patient after FDA clearance - Stock Titan
Sintx Technologies (SINT) president granted 107,143 RSUs under 2025 equity plan - Stock Titan
SINT PE Ratio & Valuation, Is SINT Overvalued - Intellectia AI
Revenue of Sintx Technologies, Inc. from 2020 to 2024 - Statista
SINTX Technologies Inc expected to post a loss of 55 cents a shareEarnings Preview - TradingView
Published on: 2026-03-11 05:25:53 - baoquankhu1.vn
Sintx Technologies director Lyons buys shares worth $24,092 By Investing.com - Investing.com South Africa
Sintx Technologies director Lyons buys shares worth $24,092 - Investing.com
Director Lyons adds 8,292 Sintx Technologies (SINT) shares in open-market buys - Stock Titan
Earnings Beat: What is the PEG ratio of Sintx Technologies Inc2025 Winners & Losers & Free Reliable Trade Execution Plans - baoquankhu1.vn
SINTX focuses on filament and partnerships: New president to bring SiN/PEEK into 3D production - 3Druck.com
SINT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
SINTX Technologies names Ryan Elmore President to drive commercial expansion of SiN biomaterials - VoxelMatters
Published on: 2026-03-02 05:18:20 - baoquankhu1.vn
SINTX Technologies signs with Evonik to produce SiN/PEEK compound for 3D printed implants - VoxelMatters
SINTX Technologies acquires SiNAPTIC Surgical assets to enter foot and ankle fusion market - voxelmatters.com
SINT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
SINTX Technologies Forms Death Cross, Signaling Potential Bearish Trend Ahead - Markets Mojo
Insider Buying: Jay Moyes Acquires Additional Shares of SINTX Te - GuruFocus
Sintx Technologies director Moyes buys $2910 in shares - Investing.com
What is the PEG ratio of Sintx Technologies Inc.Trade Volume Summary & High Accuracy Trade Alerts - mfd.ru
Is Sintx Technologies Inc. (1110) stock a buy for dividend portfoliosStop Loss & Reliable Intraday Trade Plans - mfd.ru
Finanzdaten der Sintx Technologies Inc-Aktie (SINT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):